î ƒ

Effective Internal Training Featured

How can effective internal training lead to better patient outcomes?

This case study-based webinar discusses how to connect the dots between internal training and improve patient outcomes, specifically focusing on Medical Affairs teams.
MAPS Unsorted Featured Images

The Power of Mentorship

When Robin Winter-Sperry started in the pharmaceutical industry, her mentor, Evelyn was one of the few female managers.
MedStrat 3 Featured

Medical Affairs Plans: From Strategic Planning to Measuring Impact — Episode 3

Listeners will understand how the Medical Affairs strategic planning process can drive decision making throughout the year.
Framework MSL Insights OD Featured

Building a Framework to Manage MSL Insights

This Medical Affairs webinar teaches attendees to build a framework that enables MSL insights to inform Medical strategy at both the local and global level.
EMEA Q and A Featured

EMEA 2020 Virtual Q&A

Questions submitted during EMEA 2020 sessions, answered by our speakers and panelists.
Field Medical 2 featured

Field Medical Stakeholders: Partnering for Today and Tomorrow – Episode 2 Global Product Strategy

Participants will learn the functions and activities of key internal partners and will identify potential areas for compliant collaboration with these partners.
Scientific Engagements Featured

Reimagining Scientific Engagements During COVID-19

Amgen Japan and Asia Pacific (JAPAC) Medical Affairs team shares MSL survey results to explore innovative new ways of working to serve as a model for reimagining scientific engagement during and post-COVID-19.
Digitally Transforming Featured

Digitally Transforming Your Medical Affairs Organization—Why and How to Do It!

This Medical Affairs webinar assembles leading biopharma industry experts to discuss preparing your organization for digital transformation.
RWE 2 Featured

History of Real-World Evidence Prior to the 21st Century Cures Act

Medical Affairs thought leaders discuss the Pre-21st Century Cures Act uses of Real World Evidence (RWE) in regulatory decision-making.